Kyle L. O’Donnell

525 total citations
30 papers, 321 citations indexed

About

Kyle L. O’Donnell is a scholar working on Infectious Diseases, Epidemiology and Modeling and Simulation. According to data from OpenAlex, Kyle L. O’Donnell has authored 30 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 10 papers in Epidemiology and 5 papers in Modeling and Simulation. Recurrent topics in Kyle L. O’Donnell's work include Viral Infections and Outbreaks Research (17 papers), Viral Infections and Vectors (17 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Kyle L. O’Donnell is often cited by papers focused on Viral Infections and Outbreaks Research (17 papers), Viral Infections and Vectors (17 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Kyle L. O’Donnell collaborates with scholars based in United States, Canada and United Kingdom. Kyle L. O’Donnell's co-authors include Andrea Marzi, Chad S. Clancy, David S. Bradley, Friederike Feldmann, Patrick W. Hanley, Paige Fletcher, Ilhem Messaoudi, Kyle Shifflett, Matthew L. Nilles and Jefferson A. Vaughan and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Scientific Reports.

In The Last Decade

Kyle L. O’Donnell

28 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle L. O’Donnell United States 12 207 74 51 33 27 30 321
Laura Jones United Kingdom 12 103 0.5× 71 1.0× 16 0.3× 51 1.5× 74 2.7× 24 452
Teck‐Hock Toh Malaysia 12 271 1.3× 122 1.6× 45 0.9× 42 1.3× 87 3.2× 33 486
Chong‐Tin Tan Malaysia 7 132 0.6× 185 2.5× 52 1.0× 51 1.5× 19 0.7× 19 333
Léa Lucıanı France 10 194 0.9× 61 0.8× 32 0.6× 70 2.1× 13 0.5× 35 352
Alex Mann United Kingdom 11 140 0.7× 262 3.5× 15 0.3× 68 2.1× 9 0.3× 23 453
John Wecker United States 8 364 1.8× 77 1.0× 16 0.3× 15 0.5× 15 0.6× 10 532
O. O. Kale Nigeria 15 475 2.3× 62 0.8× 147 2.9× 15 0.5× 22 0.8× 32 796
C Costin Israel 8 100 0.5× 57 0.8× 59 1.2× 13 0.4× 10 0.4× 26 290
Donald Taylor United Kingdom 4 219 1.1× 42 0.6× 17 0.3× 30 0.9× 19 0.7× 4 417
Eveline D. de Geus Netherlands 13 65 0.3× 131 1.8× 24 0.5× 55 1.7× 71 2.6× 22 393

Countries citing papers authored by Kyle L. O’Donnell

Since Specialization
Citations

This map shows the geographic impact of Kyle L. O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle L. O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle L. O’Donnell more than expected).

Fields of papers citing papers by Kyle L. O’Donnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle L. O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle L. O’Donnell. The network helps show where Kyle L. O’Donnell may publish in the future.

Co-authorship network of co-authors of Kyle L. O’Donnell

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle L. O’Donnell. A scholar is included among the top collaborators of Kyle L. O’Donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle L. O’Donnell. Kyle L. O’Donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fletcher, Paige, Kyle L. O’Donnell, Friederike Feldmann, et al.. (2025). Fast-acting single-dose vesicular stomatitis virus-Sudan virus vaccine: a challenge study in macaques. The Lancet Microbe. 6(12). 101244–101244.
2.
O’Donnell, Kyle L., Greg Saturday, Troy Hinkley, et al.. (2025). Single-dose replicon RNA Sudan virus vaccine uniformly protects female guinea pigs from disease. Nature Communications. 16(1). 4199–4199.
3.
O’Donnell, Kyle L., et al.. (2024). Vaccine Platform Comparison: Protective Efficacy against Lethal Marburg Virus Challenge in the Hamster Model. International Journal of Molecular Sciences. 25(15). 8516–8516. 2 indexed citations
4.
Fletcher, Paige, Chad S. Clancy, Kyle L. O’Donnell, et al.. (2024). Pathogenic differences of cynomolgus macaques after Taï Forest virus infection depend on the viral stock propagation. PLoS Pathogens. 20(6). e1012290–e1012290. 1 indexed citations
5.
Fletcher, Paige, Kyle L. O’Donnell, Joseph F. Rhoderick, et al.. (2024). Lack of Lloviu Virus Disease Development in Ferret Model. Emerging infectious diseases. 30(12). 2639–2642. 1 indexed citations
6.
Bushmaker, Trenton, Friederike Feldmann, Jamie Lovaglio, et al.. (2023). Limited Benefit of Postexposure Prophylaxis With VSV-EBOV in Ebola Virus–Infected Rhesus Macaques. The Journal of Infectious Diseases. 228(Supplement_7). S721–S729. 4 indexed citations
7.
Fletcher, Paige, Kyle L. O’Donnell, Brianna M. Doratt, et al.. (2023). Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection. Emerging Microbes & Infections. 12(2). 2239950–2239950. 8 indexed citations
8.
O’Donnell, Kyle L., Julie Callison, Heinz Feldmann, Thomas Hoenen, & Andrea Marzi. (2023). Single-Dose Treatment With Vesicular Stomatitis Virus–Based Ebola Virus Vaccine Expressing Ebola Virus–Specific Artificial Micro-RNA Does Not Protect Mice From Lethal Disease. The Journal of Infectious Diseases. 228(Supplement_7). S677–S681. 1 indexed citations
9.
Marzi, Andrea, Friederike Feldmann, Kyle L. O’Donnell, et al.. (2023). Preexisting Immunity Does Not Prevent Efficacy of Vesicular Stomatitis Virus–Based Filovirus Vaccines in Nonhuman Primates. The Journal of Infectious Diseases. 228(Supplement_7). S671–S676. 5 indexed citations
10.
O’Donnell, Kyle L., Friederike Feldmann, Chad S. Clancy, et al.. (2023). Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine. EBioMedicine. 89. 104463–104463. 19 indexed citations
11.
O’Donnell, Kyle L., Chad S. Clancy, Kyle Shifflett, et al.. (2022). Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters. Frontiers in Immunology. 12. 788235–788235. 14 indexed citations
12.
O’Donnell, Kyle L., et al.. (2022). Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern. Scientific Reports. 12(1). 3954–3954. 2 indexed citations
13.
O’Donnell, Kyle L., et al.. (2022). Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins. Frontiers in Immunology. 13. 1025500–1025500. 12 indexed citations
14.
Furuyama, Wakako, Kyle Shifflett, Friederike Feldmann, et al.. (2022). Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine. mBio. 13(1). e0337921–e0337921. 23 indexed citations
15.
O’Donnell, Kyle L., et al.. (2021). CD47 expression attenuates Ebola virus-induced immunopathology in mice. Antiviral Research. 197. 105226–105226. 3 indexed citations
16.
Marzi, Andrea, Allen Jankeel, Andrea Menicucci, et al.. (2021). Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease. Frontiers in Immunology. 12. 774026–774026. 33 indexed citations
17.
O’Donnell, Kyle L., Chad S. Clancy, Kyle Shifflett, et al.. (2021). Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model. EBioMedicine. 73. 103675–103675. 20 indexed citations
18.
O’Donnell, Kyle L. & Andrea Marzi. (2021). Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon. Biologics. Volume 15. 79–86. 10 indexed citations
19.
O’Donnell, Kyle L., Diego A. Espinosa, Henry Puerta‐Guardo, et al.. (2020). Avian anti-NS1 IgY antibodies neutralize dengue virus infection and protect against lethal dengue virus challenge. Antiviral Research. 183. 104923–104923. 9 indexed citations
20.
Brownstein, Catherine A., Robin J. Kleiman, Elizabeth C. Engle, et al.. (2016). Overlapping 16p13.11 deletion and gain of copies variations associated with childhood onset psychosis include genes with mechanistic implications for autism associated pathways: Two case reports. American Journal of Medical Genetics Part A. 170(5). 1165–1173. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Jones Breakdown of academic impact, for papers by Teck‐Hock Toh Breakdown of academic impact, for papers by Chong‐Tin Tan Breakdown of academic impact, for papers by Léa Lucıanı Breakdown of academic impact, for papers by Alex Mann Breakdown of academic impact, for papers by John Wecker Breakdown of academic impact, for papers by O. O. Kale Breakdown of academic impact, for papers by C Costin Breakdown of academic impact, for papers by Donald Taylor Breakdown of academic impact, for papers by Eveline D. de Geus
Rankless by CCL
2026